Skip to content

Clinical trials

Terminated Inflammatory Bowel Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Status: Terminated Country / region: United States Clear all

73 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20042
20052
20064
20083
20093
20104
20116
20121
20132
20142
20153
20167
20174
20184
20195
20207
20213
20226
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated73

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Bausch Health Americas, Inc.3
National Institute of Allergy and Infectious Diseases (NIAID)3
Pfizer3
Theravance Biopharma3
Amgen2
Direct Biologics, LLC2
Johns Hopkins University2
Prometheus Laboratories2
University of Wisconsin, Madison2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases73
Crohn Disease38
Colitis, Ulcerative27
Gastrointestinal Diseases7
Colitis5
Diarrhea4
Digestive System Diseases4
Intestinal Diseases4
Colonic Diseases3
Inflammation3

Trials

Showing 1 to 25 of 73. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.